SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-006884
Filing Date
2017-06-28
Accepted
2017-06-28 11:33:19
Documents
1
Period of Report
2017-06-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4062617mohr_delmarpharma.html 4  
1 OWNERSHIP DOCUMENT f4062617mohr_delmarpharma.xml 4 3333
  Complete submission text file 0001213900-17-006884.txt   4771
Mailing Address 8300 GREENSBORO DRIVE MCLEAN VA 22102
Business Address
Mohr Erich (Reporting) CIK: 0001298170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 17934352

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations